Evolent Health Basic EPS 2014-2025 | EVH
Evolent Health basic eps from 2014 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Evolent Health Annual Basic EPS | |
|---|---|
| 2024 | $-0.81 |
| 2023 | $-1.28 |
| 2022 | $-0.20 |
| 2021 | $-0.44 |
| 2020 | $-3.94 |
| 2019 | $-3.67 |
| 2018 | $-0.68 |
| 2017 | $-0.94 |
| 2016 | $-3.55 |
| 2015 | $13.14 |
| 2014 | $-13.46 |
| 2013 | $2.51 |
| Evolent Health Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $-0.44 |
| 2025-03-31 | $-0.63 |
| 2024-12-31 | $-0.26 |
| 2024-09-30 | $-0.27 |
| 2024-06-30 | $-0.06 |
| 2024-03-31 | $-0.22 |
| 2023-12-31 | $-0.37 |
| 2023-09-30 | $-0.30 |
| 2023-06-30 | $-0.37 |
| 2023-03-31 | $-0.24 |
| 2022-12-31 | $-0.11 |
| 2022-09-30 | $0.02 |
| 2022-06-30 | $-0.05 |
| 2022-03-31 | $-0.06 |
| 2021-12-31 | $-0.06 |
| 2021-09-30 | $-0.15 |
| 2021-06-30 | $-0.11 |
| 2021-03-31 | $-0.12 |
| 2020-12-31 | $-0.19 |
| 2020-09-30 | $-0.44 |
| 2020-06-30 | $-2.38 |
| 2020-03-31 | $-0.93 |
| 2019-12-31 | $-2.40 |
| 2019-09-30 | $-0.30 |
| 2019-06-30 | $-0.38 |
| 2019-03-31 | $-0.59 |
| 2018-12-31 | $-0.21 |
| 2018-09-30 | $-0.16 |
| 2018-06-30 | $-0.13 |
| 2018-03-31 | $-0.18 |
| 2017-12-31 | $-0.14 |
| 2017-09-30 | $-0.18 |
| 2017-06-30 | $-0.28 |
| 2017-03-31 | $-0.34 |
| 2016-12-31 | $-0.18 |
| 2016-09-30 | $-0.26 |
| 2016-06-30 | $-0.20 |
| 2016-03-31 | $-2.91 |
| 2015-12-31 | $-8.04 |
| 2015-09-30 | $-0.29 |
| 2015-06-30 | $25.69 |
| 2015-03-31 | $-4.22 |
| 2014-12-31 | $-8.22 |
| 2014-09-30 | $-2.07 |
| 2014-06-30 | $-3.17 |
| 2014-03-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.030B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Tempus AI (TEM) | United States | $13.327B | 0.00 |
| Doximity (DOCS) | United States | $12.012B | 53.44 |
| Hims & Hers Health (HIMS) | United States | $9.936B | 81.41 |
| IRhythm Technologies (IRTC) | United States | $5.355B | 0.00 |
| Hinge Health (HNGE) | United States | $4.369B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.710B | 39.83 |
| Privia Health (PRVA) | United States | $2.618B | 193.91 |
| Heartflow (HTFL) | $2.348B | 0.00 | |
| Phreesia (PHR) | United States | $1.711B | 0.00 |
| Enovis (ENOV) | United States | $1.686B | 8.91 |
| 10x Genomics (TXG) | United States | $1.631B | 0.00 |
| Omnicell (OMCL) | United States | $1.465B | 28.22 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Azenta (AZTA) | United States | $1.368B | 59.68 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Claritev (CTEV) | United States | $1.131B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.655B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Talkspace (TALK) | United States | $0.456B | 136.00 |
| Butterfly Network (BFLY) | United States | $0.350B | 0.00 |
| Carlsmed (CARL) | United States | $0.342B | 0.00 |
| TruBridge (TBRG) | United States | $0.296B | 51.87 |
| Outset Medical (OM) | United States | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.232B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.216B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.186B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.145B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.121B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.037B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| PROFUSA (PFSA) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |